There are dozens of pending lawsuits against the manufacturers of heartburn medication Zantac and its generic version, ranitidine. After Zantac was pulled off store shelves, many consumers took legal action. These civil lawsuits allege that the drug caused users to develop cancer. This is because the amount of N-nitrosodimethylamine, or NDMA, in the drug exceeded the acceptable daily limits set by the United States Food and Drug Administration.
The United States Judicial Panel on Multidistrict Litigation reports 140 lawsuits in the Zantac multidistrict litigation (MDL) as of February 19, 2020. There will likely be additional cases filed over the coming months.
Claimants filing Zantac cancer cases allege that the drug companies knew about the NDMA concern long before the drugs were pulled from shelves in late 2019. According to a USA Today report, the lawsuits allege that the drug companies could have been aware of the link between Zantac (and ranitidine) and NDMA for more than 30 years.
If this allegation can be proven in court, the stakes could become even higher for Zantac. The drug manufacturer may be forced to pay punitive damages if it can be proved that they purposefully hid the dangers of the drug from consumers.
If you file a lawsuit and present evidence to support your claim, you may be able to recover compensation for the damages you sustained as a result of your cancer diagnosis and treatment. We can help you gather evidence to prove your damages. They may include:
To recover a payout, you will need to prove that the drug you took for your heartburn caused or contributed to your cancer diagnosis. While we can help you build this type of case individually if necessary, we can also help you navigate your case as a part of multidistrict litigation. Multidistrict litigation allows all claimants to work together to gather evidence that proves their cases.
In a lawsuit against Zantac, this may include:
No matter what type of legal action you choose to take, our team can handle your case while you focus on your treatment and healing.
In 2019, several companies that make ranitidine medications pulled their drugs from the market because they contained higher than allowed levels of NDMA. Others voluntarily recalled their products because of the potential risk of NDMA exposure despite not testing above the acceptable daily intake limit. In some cases, stores pulled all ranitidine products from their shelves, including those that were not affected by the recalls.
There is evidence to link NDMA to an increased risk of cancer in animals, and it is considered a probable carcinogen in humans. NDMA causes liver cancer, lung cancer, and serious liver damage in rats, mice, hamsters, and other animals, according to the Centers for Disease Control and Prevention.
If you used Zantac or another form of ranitidine and were later diagnosed with cancer, you may be able to file a lawsuit against Zantac or join the multidistrict litigation. A Zantac cancer lawyer may be able to evaluate your case and help you weigh the pros and cons of each action.
If you took Zantac or another ranitidine drug and developed cancer, a member of the Zanes Law team can review your case today for free. We may be able to help you hold the drug manufacturer accountable and recover compensation for your expenses and losses.
Call Zanes Law today at (866) 499-8989. We can evaluate your case, answer your questions, and get you signed up for our services today. You stand to earn compensation for your medical treatments, lost wages, pain and suffering, and more.
When you are represented by Zanes Law, you can rest assured knowing that we work on a contingency-fee-basis. You pay nothing upfront in this arrangement. We only receive payment if you win a settlement or ruling in your favor in court.